Nectar Lifesciences Share Price

31.450.70 (2.28%)
Volume: 2,30,013

Closed
Last Updated On: 07 Jun, 2024, 03:53 PM IST

STOCK SCORE

ETPrime Only

TECHNICALS
COMPARE

Overview
News
Analysis
Recos
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About
More
- MF
- F&O
- Corp Actions
- About
EnglishEnglishहिन्दी ગુજરાતી मराठी বাংলা ಕನ್ನಡ தமிழ்తెలుగు

Nectar Lifesc share price insights

View All

Employee & Interest Expense
Company has spent 5.17% of its operating revenues towards interest expenses and 5.02% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -15.34% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated -15.34% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)
Nectar Lifesc Share Price Update
Nectar Lifesciences Ltd. share price moved up by 2.28% from its previous close of Rs 30.75. Nectar Lifesciences Ltd. stock last traded price is 31.45
Share Price Value
Today/Current/Last 31.4531.40
Previous Day 30.7530.78

Share Price	Value
Today/Current/Last	31.4531.40
Previous Day	30.7530.78

InsightsNectar Lifesc

Do you find these insights useful?

hate it
meh
love it

Key Metrics

PE Ratio

(x)

138.07

EPS - TTM

(₹)

0.22

MCap

(₹ Cr.)

689.60

Sectoral MCap Rank

PB Ratio

(x)

0.64

Div Yield

(%)

0.00

Face Value

(₹)

1.00

Beta

1.56

VWAP

(₹)

31.47

52W H/L

(₹)

45.70 / 17.20

Nectar Lifesc Share Price Returns

1 Day	2.28%
1 Week	-1.26%
1 Month	-6.95%
3 Months	-12.03%
1 Year	78.69%
3 Years	-11.41%
5 Years	76.69%

ET Stock ScreenersTop Score Companies

Check whether Nectar Lifesc belongs to analysts' top-rated companies list?

View Stock Screeners

Nectar Lifesc News & Analysis

View all Nectar Lifesc Share News & Announcements

Nectar Lifesc Share Analysis

Unlock Stock Score, Analyst' Ratings & Recommendations

View Stock Score on a 10-point scale
See ratings on Earning, Fundamentals, Valuation, Risk & Price
Check stock performance

JOIN ET PRIME

Nectar Lifesc Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Nectar Lifesc Financials

Income (P&L)
Balance Sheet
Cash Flow
Ratios

Insights

Employee & Interest Expense
Company has spent 5.17% of its operating revenues towards interest expenses and 5.02% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	442.84	452.65	408.57	394.60	406.74
Total Income Growth (%)	-2.17	10.79	3.54	-2.99	13.82
Total Expenses	407.57	425.35	386.41	373.91	385.57
Total Expenses Growth (%)	-4.18	10.08	3.34	-3.02	7.86
EBIT	35.27	27.30	22.16	20.68	21.17
EBIT Growth (%)	29.22	23.18	7.16	-2.29	-
Profit after Tax (PAT)	0.59	1.57	1.02	1.82	3.68
PAT Growth (%)	-62.22	54.33	-44.23	-50.49	-
EBIT Margin (%)	7.96	6.03	5.42	5.24	5.20
Net Profit Margin (%)	0.13	0.35	0.25	0.46	0.90
Basic EPS (₹)	0.03	0.07	0.05	0.08	0.16

Quarterly \| Annual	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Total Income	442.84	452.65	408.57	394.60	406.74
Total Income Growth (%)	-2.17	10.79	3.54	-2.99	13.82
Total Expenses	407.56	425.35	386.41	373.91	383.89
Total Expenses Growth (%)	-4.18	10.08	3.34	-2.60	7.39
EBIT	35.28	27.30	22.16	20.68	22.85
EBIT Growth (%)	29.24	23.18	7.16	-9.49	-
Profit after Tax (PAT)	0.60	1.57	1.02	1.82	5.36
PAT Growth (%)	-61.77	54.33	-44.23	-66.06	-
EBIT Margin (%)	7.97	6.03	5.42	5.24	5.62
Net Profit Margin (%)	0.14	0.35	0.25	0.46	1.32
Basic EPS (₹)	0.03	0.07	0.05	0.08	0.24

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,698.66	1,566.85	1,680.15	1,547.09	2,370.74
Total Revenue Growth (%)	8.41	-6.74	8.60	-34.74	-14.99
Total Expenses	1,680.39	1,609.27	1,646.07	1,606.54	2,333.27
Total Expenses Growth (%)	4.42	-2.24	2.46	-31.15	-14.53
Profit after Tax (PAT)	4.99	-24.18	25.05	-73.26	31.79
PAT Growth (%)	-	-196.55	-	-330.47	-33.22
Operating Profit Margin (%)	6.25	2.43	6.76	3.40	6.90
Net Profit Margin (%)	0.29	-1.58	1.50	-4.74	1.34
Basic EPS (₹)	0.22	-1.08	1.12	-3.27	1.42

Quarterly \| Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,698.66	1,566.85	1,679.55	1,545.62	2,367.16
Total Revenue Growth (%)	8.41	-6.71	8.67	-34.71	-15.18
Total Expenses	1,680.39	1,607.54	1,645.20	1,604.95	2,331.42
Total Expenses Growth (%)	4.53	-2.29	2.51	-31.16	-14.68
Profit after Tax (PAT)	5.00	-22.46	25.32	-73.15	30.06
PAT Growth (%)	-	-188.69	-	-343.33	-36.49
Operating Profit Margin (%)	6.25	2.54	6.78	3.41	6.83
Net Profit Margin (%)	0.29	-1.47	1.51	-4.74	1.27
Basic EPS (₹)	0.22	-1.00	8.13	-3.26	1.34

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	2,191.06	2,189.21	2,390.83	2,471.12	2,633.31
Total Assets Growth (%)	0.08	-8.43	-3.25	-6.16	-2.65
Total Liabilities	1,121.81	1,124.62	1,302.93	1,409.09	1,497.18
Total Liabilities Growth (%)	-0.25	-13.69	-7.53	-5.88	-6.42
Total Equity	1,069.25	1,064.59	1,087.91	1,062.03	1,136.13
Total Equity Growth (%)	0.44	-2.14	2.44	-6.52	2.80
Current Ratio (x)	1.32	1.59	1.56	1.04	1.29
Total Debt to Equity (x)	0.59	0.71	0.79	0.79	0.65
Contingent Liabilities	0.00	164.80	76.77	93.25	75.71

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Assets	2,191.06	2,189.21	2,389.71	2,470.20	2,632.17
Total Assets Growth (%)	0.08	-8.39	-3.26	-6.15	-2.65
Total Liabilities	1,121.81	1,124.62	1,302.84	1,409.47	1,497.56
Total Liabilities Growth (%)	-0.25	-13.68	-7.57	-5.88	-6.35
Total Equity	1,069.25	1,064.60	1,086.86	1,060.73	1,134.61
Total Equity Growth (%)	0.44	-2.05	2.46	-6.51	2.71
Current Ratio (x)	1.32	1.59	1.56	1.25	1.29
Total Debt to Equity (x)	0.59	0.71	0.79	0.79	0.65
Contingent Liabilities	0.00	164.80	76.77	93.25	75.71

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	224.69	133.65	95.01	21.38	284.96
Net Cash used in Investing Activities	-17.03	51.70	16.64	-28.62	-33.13
Net Cash flow from Financing Activities	-205.43	-185.58	-119.38	11.49	-251.87
Net Cash Flow	2.23	-0.23	-7.73	4.25	-0.03
Closing Cash & Cash Equivalent	19.81	17.58	17.81	25.54	21.29
Closing Cash & Cash Equivalent Growth (%)	12.66	-1.28	-30.27	19.94	-0.16
Total Debt/ CFO (x)	2.83	5.64	9.05	39.30	2.60

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash flow from Operating Activities	224.69	133.37	95.04	21.33	285.65
Net Cash used in Investing Activities	-17.03	52.03	16.64	-28.62	-33.14
Net Cash flow from Financing Activities	-205.43	-185.57	-119.38	11.49	-251.86
Net Cash Flow	2.23	-0.17	-7.70	4.20	0.65
Closing Cash & Cash Equivalent	19.80	17.57	17.74	25.43	21.23
Closing Cash & Cash Equivalent Growth (%)	12.70	-0.94	-30.25	19.79	3.17
Total Debt/ CFO (x)	2.83	5.65	9.05	39.39	2.59

All figures in Rs Cr, unless mentioned otherwise

View Details

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	0.46	-2.27	2.30	-6.89	2.79
Return on Capital Employed (%)	8.65	2.85	8.13	4.09	11.78
Return on Assets (%)	0.22	-1.10	1.04	-2.96	1.20
Interest Coverage Ratio (x)	1.91	1.21	2.16	0.47	1.30
Asset Turnover Ratio (x)	0.77	0.67	0.69	62.45	89.86
Price to Earnings (x)	136.99	-14.73	21.55	-5.69	6.98
Price to Book (x)	0.63	0.33	0.50	0.39	0.20
EV/EBITDA (x)	7.77	11.35	8.13	10.92	4.20
EBITDA Margin (%)	9.85	6.31	10.17	7.31	9.46

Annual	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Return on Equity (%)	0.46	-2.10	2.32	-6.89	2.64
Return on Capital Employed (%)	8.65	2.98	8.16	4.10	11.67
Return on Assets (%)	0.22	-1.02	1.05	-2.96	1.14
Interest Coverage Ratio (x)	1.91	1.23	2.16	0.47	1.28
Asset Turnover Ratio (x)	0.77	0.67	0.69	62.41	89.76
Price to Earnings (x)	135.14	-15.85	21.32	-5.70	7.38
Price to Book (x)	0.63	0.33	0.50	0.39	0.20
EV/EBITDA (x)	7.77	11.15	8.12	10.91	4.24
EBITDA Margin (%)	9.85	6.42	10.19	7.32	9.40

Financial InsightsNectar Lifesc

Income (P&L)

- Employee & Interest Expense
  Company has spent 5.17% of its operating revenues towards interest expenses and 5.02% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

Do you find these insights useful?

hate it
meh
love it

Peer Comparison

Nectar Lifesc Stock Performance
Ratio Performance

CHART
TABLE

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -15.34% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated -15.34% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Choose from Peers
Choose from Stocks

NAME	1D	1W	1M	3M	1Y	3Y	5Y
Nectar Lifesc Stock Performance	2.28	-1.26	-6.95	-12.03	78.69	-11.41	76.69
Jagsonpal Pharm Stock Performance	2.05	2.76	2.34	10.50	-7.98	158.56	1069.63
Bajaj Healthcare Stock Performance	1.67	2.39	-4.58	-12.10	0.65	0.00	0.00
Panacea Biotec Stock Performance	0.87	-1.64	-6.66	-13.41	5.40	-67.34	-26.73
Ind-Swift Labs Stock Performance	3.39	9.61	3.99	7.76	61.41	31.27	221.91
Add More

Insights

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -15.34% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated -15.34% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Nectar Lifesc	138.07	0.64	0.46	8.65	0.22	3.13	6.25	0.29	0.22	1.32	0.59	2.83
Jagsonpal Pharm	38.65	4.63	11.98	15.50	10.34	4.22	14.70	10.76	8.49	10.42	0.00	0.00
Bajaj Healthcare	-9.58	2.88	-30.10	16.37	-10.95	-10.02	12.11	-17.69	-30.36	1.16	1.19	3.60
Panacea Biotec	-832.42	0.93	-0.13	-3.32	-0.09	-2.66	-5.53	-0.26	-0.19	1.57	0.02	-209.90
Ind-Swift Labs	2.13	0.70	45.19	26.09	36.13	13.07	19.22	32.90	71.24	2.99	0.02	-0.09
Add More

Annual Ratios (%)

Choose from Peers

Albert David
Medicamen Bio
Kilitch Drug
Zim Laboratories
Wanbury Ltd

Choose from Stocks

See All Parameters

Peers InsightsNectar Lifesc

Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of -15.34% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)
Stock Returns vs Nifty Pharma
Stock generated -15.34% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

Do you find these insights useful?

hate it
meh
love it

Nectar Lifesc Shareholding Pattern

QOQ Change
Total Shareholdings

Showing Nectar Lifesc Shareholding as on 31 Mar 2024

Category	31 Mar 2024	31 Dec 2023	30 Sep 2023	30 Jun 2023
Promoters	55.80	55.80	55.80	55.80
Pledge	100.00	100.00	100.00	100.00
FII	16.98	16.12	16.02	16.00
DII	0.00	0.00	0.00	0.00
Mutual Funds	0.00	0.00	0.00	0.00
Others	27.22	28.08	28.18	28.20

Showing Shareholding as on 31 Mar 2024
Category No. of Shares Percentage % Change QoQ
Promoters 9,94,68,000 55.80 % 0.00
Pledge 9,94,68,000 100.00 % 0.00
FII 3,02,52,327 16.98 % 0.85
DII 642 0.00 % 0.00
MF 642 0.00 % 0.00
Others 9,45,40,001 27.22 % -0.85

Category	No. of Shares	Percentage	% Change QoQ
Promoters	9,94,68,000	55.80 %	0.00
Pledge	9,94,68,000	100.00 %	0.00
FII	3,02,52,327	16.98 %	0.85
DII	642	0.00 %	0.00
MF	642	0.00 %	0.00
Others	9,45,40,001	27.22 %	-0.85

MF Ownership

MF Ownership details are not available.

Corporate Actions

Nectar Lifesc Board Meeting/AGM
Nectar Lifesc Dividends
Others

Meeting Date	Announced on	Purpose	Details
May 15, 2024	May 08, 2024	Board Meeting	Audited Results
Feb 14, 2024	Jan 31, 2024	Board Meeting	Quarterly Results
Nov 10, 2023	Nov 03, 2023	Board Meeting	Quarterly Results
Sep 21, 2023	May 26, 2023	AGM	A.G.M.
Aug 14, 2023	Aug 07, 2023	Board Meeting	Quarterly Results

Type	Dividend	Dividend per Share	Ex-Dividend Date	Announced on
Final	5%	0.05	Sep 11, 2020	Jul 29, 2020
Final	5%	0.05	Sep 19, 2019	May 27, 2019
Final	5%	0.05	Sep 19, 2018	May 28, 2018
Final	5%	0.05	Sep 20, 2017	Jul 04, 2017
Final	10%	0.1	Sep 22, 2016	May 31, 2016

All Types Ex-Date Record Date Announced on Details
Splits Nov 12, 2008 Nov 20, 2008 Aug 28, 2008 Split: Old FV10.0| New FV:1.0

All Types	Ex-Date	Record Date	Announced on	Details
Splits	Nov 12, 2008	Nov 20, 2008	Aug 28, 2008	Split: Old FV10.0\| New FV:1.0

About Nectar Lifesc

Nectar Lifesciences Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 705.30 Crore) operating in Pharmaceuticals sector. Nectar Lifesciences Ltd. key Products/Revenue Segments include Pharmaceutical Products for the year ending 31-Mar-2023. Show More

Executives
Auditors

SG
Sanjiv Goyal
Chairman & Managing Director
AC
Amit Chadah
Chief Executive Officer
PS
Puneet Sud
Whole Time Director
MV
Meena Verma
Nominee Director
AS
Ajay Swaroop
Independent Director
IP
Indu Pal Kaur
Independent Director
KK
Kuldip Kumar Bhasin
Independent Director
RT
Rupinder Tewari
Independent Director
SK
Sushil Kapoor
Chief Financial Officer
NV
Neha Vaishnav
Co. Secretary & Compl. Officer
Show More
Deepak Jindal & Co
Ashwani K Gupta & Associates

Industry

Pharma - Indian

Key Indices Listed on

Address

Village Saidpura,Tehsil Derabassi,Distt. S.A.S. Nagar,Mohali, Punjab - 140507

Contact

cs@neclife.com

http://www.neclife.com

More Details

FAQs about Nectar Lifesc share

1. What's Nectar Lifesc share price today and what are Nectar Lifesc share returns ?
As on 07 Jun, 2024, 03:53 PM IST Nectar Lifesc share price was up by 2.28% basis the previous closing price of Rs 29.65. Nectar Lifesc share price was Rs 31.45. Return Performance of Nectar Lifesc Shares:
- 1 Week: Nectar Lifesc share price moved down by 1.26%
- 1 Month: Nectar Lifesc share price moved down by 6.95%
- 3 Month: Nectar Lifesc share price moved down by 12.03%
- 6 Month: Nectar Lifesc share price moved up by 9.01%
2. What are the returns for Nectar Lifesc share?
Return Performance of Nectar Lifesc Shares:
- 1 Week: Nectar Lifesc share price moved down by 1.26%
- 1 Month: Nectar Lifesc share price moved down by 6.95%
- 3 Month: Nectar Lifesc share price moved down by 12.03%
- 6 Month: Nectar Lifesc share price moved up by 9.01%
3. Who are peers to compare Nectar Lifesc share price?
Top 10 Peers for Nectar Lifesc are Albert David Ltd., Medicamen Biotech Ltd., Ind-Swift Laboratories Ltd., Panacea Biotec Ltd., Bajaj Healthcare Ltd., Kilitch Drugs(I) Ltd., Zim Laboratories Ltd., Jagsonpal Pharmaceuticals Ltd., Wanbury Ltd. and Venus Remedies Ltd.
4. What is the PE & PB ratio of Nectar Lifesc?
The PE ratio of Nectar Lifesc stands at 138.07, while the PB ratio is 0.64.
5. What is Nectar Lifesc's 52 week high / low?
52 Week high of Nectar Lifesc share is Rs 45.70 while 52 week low is Rs 17.20
6. Who's the chairman of Nectar Lifesc?
Sanjiv Goyal is the Chairman & Managing Director of Nectar Lifesc
7. How can I quickly analyze Nectar Lifesc stock?
Nectar Lifesc share can be quickly analyzed on following metrics:
- Stock's PE is 138.07
- Price to Book Ratio of 0.64
8. What are the Nectar Lifesc quarterly results?
Total Revenue and Earning for Nectar Lifesc for the year ending 2024-03-31 was Rs 1698.66 Cr and Rs 4.99 Cr on Consolidated basis. Last Quarter 2024-03-31, Nectar Lifesc reported an income of Rs 442.84 Cr and profit of Rs 0.59 Cr.
9. Who's the owner of Nectar Lifesc?
Promoter,DII and FII owns 55.8, 0.0 and 16.12 shares of Nectar Lifesc as on 31 Mar 2024
- There is no change in promoter holding from 31 Dec 2023 to 31 Mar 2024
- There is no change in Domestic Institutional Investors holding from 31 Mar 2023 to 30 Jun 2023
- Foreign Institutional Investors holding has gone up from 16.12 (31 Dec 2023) to 16.98 (31 Mar 2024)
- Other investor holding have gone down from 28.08 (31 Dec 2023) to 27.22 (31 Mar 2024)
10. What's the market capitalization of Nectar Lifesc?
Market Capitalization of Nectar Lifesc stock is Rs 689.60 Cr.
11. Who is the Chief Executive Officer of Nectar Lifesc?
Amit Chadah is the Chief Executive Officer of Nectar Lifesc
12. What dividend is Nectar Lifesc giving?
Nectar Lifesciences Ltd. announced an equity dividend of 5% on a face value of 1.0 amounting to Rs 0.05 per share on 29 Jul 2020. The ex dividend date was 11 Sep 2020.
13. What is the CAGR of Nectar Lifesc?
The CAGR of Nectar Lifesc is 2.23.

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

1 Day	2.01%
1 Week	-1.23%
1 Month	-7.05%
3 Months	-11.75%
1 Year	78.51%
3 Years	-11.42%
5 Years	76.9%

1 Month	1.99
3 Months	1.39
6 Months	1.15
1 Year	1.13
3 Years	1.43

Nectar Lifesciences Share Price